Home › European Commission grants EYLEA licence for the treatment of visual...
 

Keywords :   


European Commission grants EYLEA licence for the treatment of visual...

2014-08-13 12:58:34| Chemicals - Topix.net

Bayer HealthCare today announces that EYLEA has been approved by the European Commission for the treatment of visual impairment due to diabetic macular oedema .1 EYLEA is an established treatment for other eye conditions that could now offer patients with DMO significant visual benefits, from start of treatment, without the need for strict monthly ... (more)

Tags: treatment visual european commission

Category:Chemicals

Latest from this category

All news
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06WEG Mexico Obtains Quality Certificate from QUALICOAT
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06Sherwin-Williams Announces 2023 Water and Wastewater Impact Award Winners
Chemicals »
27.06India seeks report on iPhone factory hiring practices
27.06Atlantic Tropical Weather Outlook
27.06Eastern North Pacific Tropical Weather Outlook
27.06Korean comic giant set for $2.7bn US market debut
27.06Mechanic claims sacked for raising Boeing concerns
27.06May placements exceed expectations in June cattle on feed report
27.06Modern and precise: Using gene editing to change the blueprint of an organism
27.06Atlantic Tropical Weather Outlook
More »